Author

Maria M Zwartkruis

University Medical Center UtrechtORCID 0000-0002-8868-7155Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:long-read sequencing· 1 Assay:protein structure· 1

Frequent Co-Authors

Ewout J. N. GroeniD· 2 shared Fay‐Lynn AsselmaniD· 2 shared Ilaria SignoriaiD· 2 shared Jared W Green· 2 shared Joris V Kortooms· 2 shared Renske I. WadmaniD· 2 shared W. Ludo van der PoliD· 2 shared Demi GommersiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Ewout J. N. GroenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicineiSciencePeer-reviewedApr 17, 2025

Comprehensive analysis across SMN2 excludes DNA methylation as an epigenetic biomarker for spinal muscular atrophy

Maria M Zwartkruis, Joris V Kortooms, Demi Gommers…·Ewout J. N. Groen

This study analyzes SMN2 DNA methylation in SMA patients and finds no association with disease severity or treatment response, but identifies age-related methylation changes.

5 citations

humanlong-read sequencing

Molecular BiologyMolecular Therapy — Methods & Clinical DevelopmentPeer-reviewedNov 13, 2024

Patient-specific responses to SMN2 splice-modifying treatments in spinal muscular atrophy fibroblasts

Ilaria Signoria, Maria M Zwartkruis, Lotte Geerlofs…·Ewout J. N. Groen

The paper analyzes responses to SMN2 splice-modifying treatments in SMA fibroblasts, finding variability in treatment efficacy based on patient-specific factors.

10 citations

humanbulk RNA-seq